Last reviewed · How we verify
Prolonged perioperative antibiotics
At a glance
| Generic name | Prolonged perioperative antibiotics |
|---|---|
| Also known as | cefoxitin followed by 3-day cefotaxime plus metronidazole |
| Sponsor | Asan Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics (PHASE2, PHASE3)
- Duration of Perioperative Antibiotics in Pancreatoduodenectomy (NA)
- The Effect of Bundle Application on Surgical Site Infection (NA)
- Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) (PHASE4)
- Enhanced Recovery Protocol in Urogynecologic Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Prolonged perioperative antibiotics CI brief — competitive landscape report
- Prolonged perioperative antibiotics updates RSS · CI watch RSS
- Asan Medical Center portfolio CI